<p>All parameters expressed as median and (interquartile range) unless indicated. HALS = HIV-1/HAART-associated lipodystrophy syndrome, ART = antiretroviral therapy, PI = protease inhibitor, NNRTI = non-nucleoside reverse transcriptase inhibitor, NRTI = nucleoside reverse transcriptase inhibitor. *There were not individual druga exposure differences (P<0.1) for stavudine, tenofovir, zidovudine, zalcitabine, abacavir, and nevirapine, m = months, 3TC = lamivudine, FTC = emtricitabine, ddI = didanosine, EFV = efavirenz, m = months.</p
<p>NRTI: nucleoside reverse transcriptase inhibitors (abacavir, emtricitabine, lamivudine and tenofo...
BACKGROUND: Data on adverse events to antiretroviral treatment have been recorded in clinical trials...
BACKGROUND: Data on adverse events to antiretroviral treatment have been recorded in clinical trials...
<p>All parameters expressed as median and (interquartile range) unless indicated. HALS = HIV-1/HAART...
<p><b>NOTE.</b> Data are expressed as mean ± SD or number (percent). <sup>a</sup>Independent sample ...
<p><b>Note</b>: The comorbidities include hypertension, diabetes mellitus, hyperlipidemia, coronary ...
BackgroundSmall intensive pharmacokinetic (PK) studies of medications in early-phase trials cannot i...
*<p>NRTI = Nucleoside reverse transcriptase inhibitor, ARV = Antiretroviral; BMI = Body Mass Index; ...
BackgroundSmall intensive pharmacokinetic (PK) studies of medications in early-phase trials cannot i...
BackgroundSmall intensive pharmacokinetic (PK) studies of medications in early-phase trials cannot i...
<p>Resistance level was estimated according to the HIVdb Interpretation Algorithm (Stanford Universi...
OBJECTIVES: To assess the inter-individual and intra-individual plasma concentration variabilities ...
<p>Nucleotide/side reverse transcriptase inhibitors (N(t)RTIs): lamivudine (3TC), tenofovir (TDF), z...
OBJECTIVE: To investigate the relationship between exposure to antiretroviral drugs and the initial ...
<p>Values are median <i>(interquartile range)</i>.</p><p>ART: Highly active antiretroviral therapy; ...
<p>NRTI: nucleoside reverse transcriptase inhibitors (abacavir, emtricitabine, lamivudine and tenofo...
BACKGROUND: Data on adverse events to antiretroviral treatment have been recorded in clinical trials...
BACKGROUND: Data on adverse events to antiretroviral treatment have been recorded in clinical trials...
<p>All parameters expressed as median and (interquartile range) unless indicated. HALS = HIV-1/HAART...
<p><b>NOTE.</b> Data are expressed as mean ± SD or number (percent). <sup>a</sup>Independent sample ...
<p><b>Note</b>: The comorbidities include hypertension, diabetes mellitus, hyperlipidemia, coronary ...
BackgroundSmall intensive pharmacokinetic (PK) studies of medications in early-phase trials cannot i...
*<p>NRTI = Nucleoside reverse transcriptase inhibitor, ARV = Antiretroviral; BMI = Body Mass Index; ...
BackgroundSmall intensive pharmacokinetic (PK) studies of medications in early-phase trials cannot i...
BackgroundSmall intensive pharmacokinetic (PK) studies of medications in early-phase trials cannot i...
<p>Resistance level was estimated according to the HIVdb Interpretation Algorithm (Stanford Universi...
OBJECTIVES: To assess the inter-individual and intra-individual plasma concentration variabilities ...
<p>Nucleotide/side reverse transcriptase inhibitors (N(t)RTIs): lamivudine (3TC), tenofovir (TDF), z...
OBJECTIVE: To investigate the relationship between exposure to antiretroviral drugs and the initial ...
<p>Values are median <i>(interquartile range)</i>.</p><p>ART: Highly active antiretroviral therapy; ...
<p>NRTI: nucleoside reverse transcriptase inhibitors (abacavir, emtricitabine, lamivudine and tenofo...
BACKGROUND: Data on adverse events to antiretroviral treatment have been recorded in clinical trials...
BACKGROUND: Data on adverse events to antiretroviral treatment have been recorded in clinical trials...